Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (349K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Brázdová, M.
Right arrow Articles by Palecek, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brázdová, M.
Right arrow Articles by Palecek, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2002, Vol. 30, No. 22 4966-4974
© 2002 Oxford University Press

Role of tumor suppressor p53 domains in selective binding to supercoiled DNA

Marie Brázdová, Jan Palecek, Dmitry I. Cherny1,2, Sabina Billová, Miroslav Fojta, Petr Pecinka, Borivoj Vojtesek3, Thomas M. Jovin1 and Emil Palecek*

Institute of Biophysics, Academy of Sciences of the Czech Republic, Kralovopolská 135, 612 65 Brno, Czech Republic, 1 Department of Molecular Biology, Max Planck Institute for Biophysical Chemistry, 37070 Göttingen, Germany, 2 Institute of Molecular Genetics, Russian Academy of Sciences, Kurchatov’s Square, Moscow, Russia and 3 Masaryk Memorial Cancer Institute, Zluty Kopec 7, 656 53 Brno, Czech Republic

*To whom correspondence should be addressed. Tel: +420 5 41517 180; Fax: +420 5 41211 293; Email: palecek{at}ibp.cz
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors

We showed previously that bacterially expressed full-length human wild-type p53b(1–393) binds selectively to supercoiled (sc)DNA in sc/linear DNA competition experiments, a process we termed supercoil-selective (SCS) binding. Using p53 deletion mutants and pBluescript scDNA (lacking the p53 recognition sequence) at native superhelix density we demonstrate here that the p53 C-terminal domain (amino acids 347–382) and a p53 oligomeric state are important for SCS binding. Monomeric p53(361–393) protein (lacking the p53 tetramerization domain, amino acids 325–356) did not exhibit SCS binding while both dimeric mutant p53(319– 393)L344A and fusion protein GCN4–p53(347–393) were effective in SCS binding. Supershifting of p53(320–393)–scDNA complexes with monoclonal antibodies revealed that the amino acid region 375–378, constituting the epitope of the Bp53-10.1 antibody, plays a role in binding of the p53(320–393) protein to scDNA. Using electron microscopy we observed p53–scDNA nucleoprotein filaments produced by all the C-terminal proteins that displayed SCS binding in the gel electrophoresis experiments; no filaments formed with the monomeric p53(361– 393) protein. We propose a model according to which two DNA duplexes are compacted into p53–scDNA filaments and discuss a role for filament formation in recombination.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Ma, Y. Pan, K. Gunasekaran, R. B. Venkataraghavan, A. J. Levine, and R. Nussinov
Comparison of the protein-protein interfaces in the p53-DNA crystal structures: Towards elucidation of the biological interface
PNAS, March 15, 2005; 102(11): 3988 - 3993.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Kasparkova, M. Fojta, N. Farrell, and V. Brabec
Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin
Nucleic Acids Res., October 14, 2004; 32(18): 5546 - 5552.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.